- Country: Czech Republic
- Summary: Medicinal Products Containing Palonosetron Combination, Granisetron, Ondasetron
- CZT Ref No: 116724456
- Deadline: 25 Apr 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: CZK 2276300
- Notice Type: Tender
- Document Ref. No.: 191985-2025
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- The subject of the public contract is continuous supplies of medicinal products containing palonosetron combinations, granisetron, ondansetron for 4 years according to the current needs of the contracting authority.Granisetron-hydrochloride 2mg tbl FLM 5
Part 3
Granisetron-hydrochloride 1mg/ml Inj Sol 5x3ml
Part 4
OndaSetron 4MG POR TBL Di 5
dihydrate of OndaSetron-hydrochloride 2mg/ml Inj Sol 5x4ml
DOC TITLE: Medicinal preparationscontaining palonosetron combinations, granisetron, ondansetron
Contract Type: Supplies - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINMedicinal Products Containing Palonosetron Combination, Granisetron, Ondasetron - Czech Tender
The UNIVERSITY HOSPITAL HRADEC KRALOVE, a Government sector organization in Czech Republic, has announced a new tender for Medicinal Products Containing Palonosetron Combination, Granisetron, Ondasetron. This tender is published on CzechTenders under CZT Ref No: 116724456 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-04-25.
The estimated tender value is CZK 2276300, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
